MyAverix Finance
SHG · Healthcare
Mayinglong Pharmaceutical Group Co Ltd (600993)
Drug Manufacturers - Specialty & Generic
Mayinglong Pharmaceutical Group Co Ltd (600993) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $10.97B, P/E ratio is 19.13, net margin is 15.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600993
Mayinglong Pharmaceutical Group Co Ltd (600993) — FAQ
What is Mayinglong Pharmaceutical Group Co Ltd's market cap?
Mayinglong Pharmaceutical Group Co Ltd (600993) has a reported market cap of $10.97B (data as of 2026-03-28).
What is 600993's P/E ratio?
The price-to-earnings (P/E) ratio for Mayinglong Pharmaceutical Group Co Ltd (600993) is 19.13 (data as of 2026-03-28).
Does Mayinglong Pharmaceutical Group Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Mayinglong Pharmaceutical Group Co Ltd (600993). Check the MyAverix Finance app for the latest dividend data.
What sector is Mayinglong Pharmaceutical Group Co Ltd in?
Mayinglong Pharmaceutical Group Co Ltd (600993) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600993 listed on?
600993 is listed on SHG.
What is Mayinglong Pharmaceutical Group Co Ltd's net margin?
Mayinglong Pharmaceutical Group Co Ltd (600993) reports a net margin of 15.2% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.